Market Currents
MannKind (MNKD): Q3 EPS of -$0.42 beats by $0.06, on no revenue. "While we continue to be fully...
-
Monday, November 2, 2009, 4:20 PM ETMannKind (MNKD): Q3 EPS of -$0.42 beats by $0.06, on no revenue. "While we continue to be fully engaged in the task of navigating our NDA through the FDA review process, we are continuing to run additional studies of AFRESA." Shares +1.5% AH. (PR)
Other date
Latest Articles
This news story has 1 comment: